Search
Carolyn Y. Johnson in The Boston Globe
- 4 min
Behind potent drug names, a complex mix of ingredients
Firms must navigate legal and linguistic hurdles for approval They are the public face of products that can take many years and hundreds...
Steve Arnoff / Accessable Medicines
- 3 min
Introducing The New Association For Accessible Medicines (AAM)
The Generic Pharmaceutical Association (GPhA), the US largest trade group representing generic pharmaceutical and biosimilar companies,...
By Caroline Hroncich From BioPharm International
- 2 min
FDA Reiterates Decision on Suffixes in Biosimilar Naming
A Federal Register notice from FDA addressed comments on the guidance on Proprietary Naming of Biological Products and the agency’s...